{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T23:46:24Z","timestamp":1777333584354,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"DOI":"10.1186\/s13000-026-01776-w","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T01:33:56Z","timestamp":1773884036000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathological and prognostic significance of stromal maturity, tumour-infiltrating lymphocytes, and systemic environment in breast cancer"],"prefix":"10.1186","volume":"21","author":[{"given":"Qing","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhua","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shudong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiabei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"1776_CR1","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.1158\/1078-0432.CCR-24-0459","volume":"30","author":"P Jank","year":"2024","unstructured":"Jank P, Karn T, van Mackelenbergh M, Lindner J, Treue D, Huober J, et al. An analysis of PIK3CA hotspot mutations and response to neoadjuvant therapy in patients with breast cancer from four prospective clinical trials. Clin Cancer Res. 2024;30:3868\u201380.","journal-title":"Clin Cancer Res"},{"key":"1776_CR2","doi-asserted-by":"publisher","first-page":"2398297","DOI":"10.1080\/15384047.2024.2398297","volume":"25","author":"S Liu","year":"2024","unstructured":"Liu S, Xu T, Chen X, Tang L, Li L, Zhang L, et al. TP53AIP1 induce autophagy via the AKT\/mTOR signaling pathway in the breast cancer cells. Cancer Biol Ther. 2024;25:2398297.","journal-title":"Cancer Biol Ther"},{"key":"1776_CR3","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.1007\/s43032-024-01666-w","volume":"31","author":"P Pourmasoumi","year":"2024","unstructured":"Pourmasoumi P, Moradi A, Bayat M. BRCA1\/2 mutations and breast\/ovarian cancer risk: a new insights review. Reprod Sci. 2024;31:3624\u201334.","journal-title":"Reprod Sci"},{"key":"1776_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13045-019-0770-1","volume":"12","author":"T Liu","year":"2019","unstructured":"Liu T, Han C, Wang S, Fang P, Ma Z, Xu L, et al. Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy. J Hematol Oncol. 2019;12:86.","journal-title":"J Hematol Oncol"},{"key":"1776_CR5","doi-asserted-by":"publisher","first-page":"104471","DOI":"10.1016\/j.critrevonc.2024.104471","volume":"202","author":"M Aizaz","year":"2024","unstructured":"Aizaz M, Khan AS, Khan M, Musazade E, Yang G. Advancements in tumor-infiltrating lymphocytes: historical insights, contemporary milestones, and future directions in oncology therapy. Crit Rev Oncol Hematol. 2024;202:104471.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1776_CR6","doi-asserted-by":"publisher","unstructured":"Wang K, Xie CJ, Ding Z, Shan T, Zhong Z, Yuan FL et al. PDE5A+ cancer-associated fibroblasts enhance immune suppression in gastric cancer. Gut. 2025;gutjnl-2025-335794. https:\/\/doi.org\/10.1136\/gutjnl-2025-335794.","DOI":"10.1136\/gutjnl-2025-335794"},{"key":"1776_CR7","doi-asserted-by":"publisher","first-page":"216985","DOI":"10.1016\/j.canlet.2024.216985","volume":"595","author":"DJ Agorku","year":"2024","unstructured":"Agorku DJ, Bosio A, Alves F, Str\u00f6bel P, Hardt O. Colorectal cancer-associated fibroblasts inhibit effector T cells via NECTIN2 signaling. Cancer Lett. 2024;595:216985.","journal-title":"Cancer Lett"},{"key":"1776_CR8","doi-asserted-by":"publisher","first-page":"642","DOI":"10.2174\/0115680096261142231018104854","volume":"24","author":"W Yang","year":"2024","unstructured":"Yang W, Chen Z, Qu L, Zhang C, Chen H, Zheng J, et al. IR-780 dye-based targeting of cancer-associated fibroblasts improves cancer immunotherapy by increasing intra-tumoral T lymphocytes infiltration. Curr Cancer Drug Targets. 2024;24:642\u201353.","journal-title":"Curr Cancer Drug Targets"},{"key":"1776_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00428-019-02742-2","volume":"477","author":"T Ao","year":"2020","unstructured":"Ao T, Kajiwara Y, Yonemura K, Shinto E, Mochizuki S, Okamoto K, et al. Morphological consistency of desmoplastic reactions between the primary colorectal cancer lesion and associated metastatic lesions. Virchows Arch. 2020;477:47\u201355.","journal-title":"Virchows Arch"},{"key":"1776_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/annonc\/mdu450","volume":"26","author":"R Salgado","year":"2015","unstructured":"Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an international TILs working group 2014. Ann Oncol. 2015;26:259\u201371.","journal-title":"Ann Oncol"},{"key":"1776_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/his.14091","volume":"77","author":"PH Tan","year":"2020","unstructured":"Tan PH, Ellis I, Allison K, Brogi E, Fox SB, Lakhani S, et al. The 2019 World Health Organization classification of tumours of the breast. Histopathology. 2020;77:181\u20135.","journal-title":"Histopathology"},{"key":"1776_CR12","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.1158\/1078-0432.CCR-18-0205","volume":"24","author":"T Kato","year":"2018","unstructured":"Kato T, Noma K, Ohara T, Kashima H, Katsura Y, Sato H, et al. Cancer-associated fibroblasts affect intratumoral CD8\u2009+\u2009and FoxP3\u2009+\u2009T cells via IL6 in the tumor microenvironment. Clin Cancer Res. 2018;24:4820\u201333.","journal-title":"Clin Cancer Res"},{"key":"1776_CR13","doi-asserted-by":"publisher","first-page":"110567","DOI":"10.1016\/j.cellsig.2022.110567","volume":"103","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Wang Y, Liu F. Cancer-associated fibroblasts: versatile mediators in remodeling the tumor microenvironment. Cell Signal. 2023;103:110567.","journal-title":"Cell Signal"},{"key":"1776_CR14","doi-asserted-by":"publisher","first-page":"115622","DOI":"10.1016\/j.biopha.2023.115622","volume":"167","author":"D Gao","year":"2023","unstructured":"Gao D, Fang L, Liu C, Yang M, Yu X, Wang L, et al. Microenvironmental regulation in tumor progression: interactions between cancer-associated fibroblasts and immune cells. Biomed Pharmacother. 2023;167:115622.","journal-title":"Biomed Pharmacother"},{"key":"1776_CR15","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41568-024-00740-4","volume":"24","author":"L Arpinati","year":"2024","unstructured":"Arpinati L, Carradori G, Scherz-Shouval R. CAF-induced physical constraints controlling T cell state and localization in solid tumours. Nat Rev Cancer. 2024;24:676\u201393.","journal-title":"Nat Rev Cancer"},{"key":"1776_CR16","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1002\/wjs.12269","volume":"48","author":"S Suzuki","year":"2024","unstructured":"Suzuki S, Nagakawa Y, Miyamoto R, Osakabe H, Kiya Y, Yamaguchi H, et al. Prognostic factors based on histological categorization of desmoplastic reactions in pancreatic cancer. World J Surg. 2024;48:1973\u201380.","journal-title":"World J Surg"},{"key":"1776_CR17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jare.2024.05.031","volume":"71","author":"Y Liu","year":"2025","unstructured":"Liu Y, Zhang X, Gu W, Su H, Wang X, Wang X, et al. Unlocking the crucial role of cancer-associated fibroblasts in tumor metastasis: mechanisms and therapeutic prospects. J Adv Res. 2025;71:399\u2013413.","journal-title":"J Adv Res"},{"key":"1776_CR18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12916-015-0431-3","volume":"13","author":"S Dushyanthen","year":"2015","unstructured":"Dushyanthen S, Beavis PA, Savas P, Teo ZL, Zhou C, Mansour M, et al. Relevance of tumor-infiltrating lymphocytes in breast cancer. BMC Med. 2015;13:202.","journal-title":"BMC Med"},{"key":"1776_CR19","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/s41586-025-09303-5","volume":"645","author":"J Heide","year":"2025","unstructured":"Heide J, Bilecz AJ, Patnaik S, Allega MF, Donle L, Yang K, et al. NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity. Nature. 2025;645:1051\u20139.","journal-title":"Nature"},{"key":"1776_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000508337","volume":"87","author":"A Kariri Yousif","year":"2020","unstructured":"Kariri Yousif A, Aleskandarany Mohammed A, Joseph C, Kurozumi S, Mohammed Omar J, Toss Michael S, et al. Molecular complexity of lymphovascular invasion: the role of cell migration in breast cancer as a prototype. Pathobiology. 2020;87:218\u201331.","journal-title":"Pathobiology"},{"key":"1776_CR21","doi-asserted-by":"publisher","first-page":"e0177137","DOI":"10.1371\/journal.pone.0177137","volume":"12","author":"H Takeuchi","year":"2017","unstructured":"Takeuchi H, Kawanaka H, Fukuyama S, Kubo N, Hiroshige S, Yano T. Comparison of the prognostic values of preoperative inflammation-based parameters in patients with breast cancer. PLoS ONE. 2017;12:e0177137.","journal-title":"PLoS ONE"},{"key":"1776_CR22","doi-asserted-by":"publisher","first-page":"112365","DOI":"10.1016\/j.nut.2024.112365","volume":"121","author":"H Xie","year":"2024","unstructured":"Xie H, Jia P, Wei L, Ruan G, Zhang H, Ge Y, et al. Evaluation and validation of neutrophil to albumin ratio as a promising prognostic marker for all-cause mortality in patients with cancer: a multicenter cohort study. Nutrition. 2024;121:112365.","journal-title":"Nutrition"},{"key":"1776_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-023-01744-8","volume":"22","author":"Z Yuan","year":"2023","unstructured":"Yuan Z, Li Y, Zhang S, Wang X, Dou H, Yu X, et al. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. Mol Cancer. 2023;22:48.","journal-title":"Mol Cancer"},{"key":"1776_CR28","doi-asserted-by":"crossref","unstructured":"Triulzi T, Casalini P, Sandri M, Ratti M, Carcangiu ML, Colombo MP, et al. Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress. PLoS One. 2013;8:e56761.","DOI":"10.1371\/journal.pone.0056761"},{"key":"1776_CR29","doi-asserted-by":"crossref","unstructured":"Kakumoto A, Jamiyan T, Koyanagi A, Kuroda H, Yamaguchi R, Tsuda H, et al. Prognostic impact of tumor\u2011associated stroma in triple-negative breast cancer. Breast Cancer. 2025;32:347\u201356.","DOI":"10.1007\/s12282-024-01661-8"},{"key":"1776_CR30","doi-asserted-by":"crossref","unstructured":"Lu X, Luo B, Wei Y, Bu H, Gou Z. Histological categorization of desmoplastic reaction in triple-negative breast cancer: its relevance to neoadjuvant chemoimmunotherapy response and tumor biology. Mod Pathol. 2026;39:100943.","DOI":"10.1016\/j.modpat.2025.100943"},{"key":"1776_CR31","doi-asserted-by":"crossref","unstructured":"Heater NK, Warrior S, Lu J. Current and future immunotherapy for breast cancer. J Hematol Oncol. 2024;17:131.","DOI":"10.1186\/s13045-024-01649-z"},{"key":"1776_CR32","doi-asserted-by":"crossref","unstructured":"Yang Z, Liu X, Zhu J, Chai Y, Cong B, Li B, et al. Inhibiting intracellular CD28 in cancer cells enhances antitumor immunity and overcomes anti-PD-1 resistance via targeting PD-L1. Cancer Cell. 2025;43:86\u2013e10210.","DOI":"10.1016\/j.ccell.2024.11.008"},{"key":"1776_CR33","doi-asserted-by":"crossref","unstructured":"Mentucci FM, Ferrara MG, Ercole A, Vittar NBR, Lamberti MJ. Interplay between cancer-associated fibroblasts and dendritic cells: implications for tumor immunity. Front Immunol. 2025;16:1515390.","DOI":"10.3389\/fimmu.2025.1515390"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-026-01776-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-026-01776-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-026-01776-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T23:18:07Z","timestamp":1777331887000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13000-026-01776-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1776"],"URL":"https:\/\/doi.org\/10.1186\/s13000-026-01776-w","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Wuxi People\u2019s Hospital Affiliated with Nanjing Medical University (KY25007).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}